| Serologic studies on schizophrenic patients. | |
| | |
MedLine Citation:
|
PMID: 687795 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We studied the capacity of sera from schizophrenic patients and from normal blood bank donors to agglutinate sheep erythrocytes coated with extracts of human brain. Passive hemagglutination of coated erythrocytes was obtained with 36.4% of the assayed sera of the schizophrenia patients and with 11% of the control sera. Drug treatment did not seem to play a major role in the reactivity because the patients were either never treated before or a period of several weeks was allowed since treatment until blood was drawn. Furthermore, the analysis of sera obtained by sequential bleedings of patients on drug therapy showed that drugs did not affect the serologic activity. |
| | |
Authors:
|
R Anavi; M Baron; I P Witz |
Related Documents
:
|
7718935 - Single-photon emission computed tomography of the brain in acute mania and schizophrenia. 3488765 - Pathological cerebral blood flow during motor function in schizophrenic and endogenous ... 2027435 - Slow cortical potentials (scps) in schizophrenic patients during performance of the wis... 11186095 - A narcoleptic patient exhibiting hallucinations and delusion. 21263415 - Evaluation and treatment of cardiovascular diseases in patients on hemodialysis--single... 21951785 - Detection of metabolites in the white matter of frontal lobes and hippocampus with prot... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Birth defects original article series Volume: 14 ISSN: 0547-6844 ISO Abbreviation: Birth Defects Orig. Artic. Ser. Publication Date: 1978 |
Date Detail:
|
Created Date: 1978-11-22 Completed Date: 1978-11-22 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0003403 Medline TA: Birth Defects Orig Artic Ser Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 297-309 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Bipolar Disorder / immunology Caudate Nucleus / immunology Cerebellum / immunology Chlorpromazine / therapeutic use Erythrocytes / immunology Female Hemagglutination Tests Humans Lung / immunology Male Middle Aged Schizophrenia / drug therapy, immunology* Septal Nuclei / immunology Spleen / immunology Tissue Extracts / immunology |
| Chemical | |
Reg. No./Substance:
|
0/Tissue Extracts; 50-53-3/Chlorpromazine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Alterations in behavior resulting from persistent lymphocytic choriomeningitis virus infection.
Next Document: Comparative assessment of circulatory and respiratory maintenance by hemoglobin dissolved in plasma ...